The investigation of TRPV1’s involvement in autoimmune conditions such as systemic lupus erythematosus, multiple sclerosis, and rheumatoid arthritis highlights its potential as a therapeutic target. This evidence concerns the gene TRPV1 and multiple sclerosis.